Live Breaking News & Updates on Merck Co Inc Keytruda
Stay updated with breaking news from Merck co inc keytruda. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
NetScientific PLC - London-based deep tech and life sciences-focused venture capital investment company - Reports that its portfolio company, PDS Biotechnology Corp, has announced updated interim. ....
AstraZeneca Plc (NASDAQ: AZN) reported high-level results from the TROPION-Lung01 Phase 3 trial of datopotamab deruxtecan (Dato-DXd) in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) treated with at ....
Health: US FDA proposes higher bar for accelerated approvals for cancer drugs gdnonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gdnonline.com Daily Mail and Mail on Sunday newspapers.
ADVAXIS INC (ADXS) - Advaxis' ADXS-503 Shows Durable Benefit Beyond One Year in Lung Cancer Patients Progressing on Merck's Keytruda benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.
Genprex in-licenses additional gene therapy technologies to treat non-small cell lung cancer The newly licensed intellectual property includes methods for treating NSCLC by administration of a TUSC2 therapeutic in conjunction with EGFR inhibitors or other anti-cancer therapies in patients The announcement with a major cancer research center in Houston comes as Genprex prepares to launch a pair of clinical trials involving REQORSA Genprex Inc (NASDAQ:GNPX) said that a major cancer research center in Houston has granted it an exclusive worldwide license for an additional portfolio of six patents and one patent application and related technology for lung cancer treatment. ....